
Mylan Pharmaceuticals Hit with Another Class Action Over EpiPen Prices
November 9, 2016 A new class action out of California against Mylan Pharmaceuticals and Mylan Specialty L.P. claims the companies illegally inflated the cost of its flagship EpiPen.